Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma

29 Apr 2021

Abstract excerpt

Glioma is the most common primary intracranial malignant tumor in adults. Although there have been many efforts on potential targeted therapy of glioma, the patient's prognosis remains dismal. Methyltransferase Like 7B (METTL7B) has been found to affect the development of a variety of tumors. In this study, we collected RNA-seq data of glioma in CGGA and TCGA, analyzed them separately. Then, Kaplan-Meier survival...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Ferroptosis and cancer prognosis
RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33996568
DOI: 10.3389/fonc.2021.650534

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in GliomaPMID 33996568Read ↗

Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in GliomaSemantic proximity Read ↗

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity Read ↗

Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in gliomaSemantic proximity Read ↗

Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in gliomaSemantic proximity Read ↗

Large-scale analysis reveals the specific clinical and immune features of B7-H3 in gliomaSemantic proximity Read ↗

Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in gliomaSemantic proximity Read ↗

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma PrognosisSemantic proximity Read ↗

A bioinformatic analysis study of m7G regulator-mediated methylation modification patterns and tumor microenvironment infiltration in glioblastomaSemantic proximity Read ↗

Developing a Novel Prognostic Model for Low-grade Glioma Based on m6A-Associated Immune Genes and Identifying a New BiomarkerSemantic proximity Read ↗

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in GliomasSemantic proximity Read ↗

Crosstalk between CD180-overexpression macrophages and glioma cells worsens patient survival through malignant phenotype promotion and immunosuppressive regulation.Semantic proximity Read ↗

SLC12A9 is an immunological and prognostic biomarker for glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.